It is tempting to speculate that the increase in glucose uptake and elevated proliferation rates associated with the in situ tumor growth may provoke a rapid consumption of ENO1, the master regulator of tumor metabolism, and in turn an aberrant release of the enzyme. Here, ENO1 is linked to neoplasm.